In January, after the DermaSensor became the first artificial intelligence (AI)-enabled device cleared by the US Food and Drug Administration (FDA) to evaluate lesions suggestive of skin cancer, the ...

TALLAHASSEE, Fla.--(BUSINESS WIRE)--DermaSensor Inc., a health technology company equipping primary care physicians (PCPs) with a non-invasive device for evaluating suspicious skin lesions and a proud ...

Symmetrical—lesions appear to be distributed in a similar arrangement on differing sides of the body (Figure 3, see slideshow) Once the configuration and distribution has been determined, the next ...

Please provide your email address to receive an email when new articles are posted on . The device is a handheld tool that uses spectroscopy and algorithms to test worrisome skin lesions for cancer.

An artificial intelligence (AI)–enabled handheld elastic scattering spectroscopy (ESS) device improved the sensitivity for skin cancer diagnosis and management by primary care physicians (PCPs), with ...

This is read by an automated voice. Please report any issues or inconsistencies here. State-reported data in Arizona identified a massive detection gap: 215 melanomas in a year compared to the average ...

A mobile app that uses artificial intelligence, AI, to analyze images of suspected skin lesions can diagnose melanoma with very high precision, according to a new study. A mobile app that uses ...

This was a retrospective study using data from our institutional medical records and pathological archives. SNAF was suspected when a grossly abnormal lesion was spatially related to the reconstructed ...

This condition, often referred to as chronic pruritus without primary skin lesions, is surprisingly common—especially in older adults. What makes it challenging is that the skin may appear almost ...

How Specialist Skin Cancer Surgery Supports Confidence After Diagnosis Blackburn, United Kingdom - June 18, 2026 / Dr, ...